Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer

医学 甲状腺结节 甲状腺癌 甲状腺乳突癌 甲状腺 贝塞斯达系统 内科学 放射科 普通外科
作者
Max A. Schumm,Michelle L. Shu,Elena G Hughes,Yuri E. Nikiforov,Marina N. Nikiforova,Abigail I. Wald,Melissa G. Lechner,Chi‐Hong Tseng,Dipti P. Sajed,James X. Wu,Michael W. Yeh,Masha Jean Livhits
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:149 (8): 735-735 被引量:47
标识
DOI:10.1001/jamaoto.2023.1494
摘要

Importance: Molecular testing is commonly used in the diagnosis of thyroid nodules with indeterminate cytology. The role of molecular testing in prognosticating oncologic outcomes in thyroid nodules with suspicious or malignant cytology is unclear. Objective: To determine whether molecular profiling of Bethesda V (suspicious for thyroid cancer) and VI (thyroid cancer) nodules is associated with improved prognostication and whether it may inform initial treatment. Design, Setting, and Participants: This retrospective cohort study included consecutive patients with Bethesda V or VI nodules who underwent surgery, with histopathology showing differentiated thyroid cancer, between May 1, 2016, and July 31, 2019 in the University of California, Los Angeles health system. Data were analyzed between April 2, 2021, and January 18, 2023. Exposures: Masked ThyroSeq, version 3 molecular analysis after completion of initial treatment and acquisition of follow-up data. Main Outcomes and Measures: Structural disease persistence or recurrence, distant metastasis, and recurrence-free survival were assessed using ThyroSeq Cancer Risk Classifier (CRC) molecular risk groups (low, RAS-like; intermediate, BRAF-like; high, combination of BRAF/RAS plus TERT or other high-risk alterations) using Cox proportional hazards regression models. Results: In 105 patients with papillary thyroid cancer (median [IQR] follow-up, 3.8 [3.0-4.7] years), ThyroSeq identified genomic alterations in 100 (95%) samples (6 [6%] low risk, 88 [88%] intermediate risk, and 6 [6%] high risk; median [IQR] age, 44 [34-56] years; 68 [68%] female and 32 [32%] male). No patients with low-risk or negative results experienced recurrence. Of the 88 patients with intermediate risk, 6 (7%) experienced local recurrence, with 1 of them also developing distant metastasis. The 6 patients with high risk (all with BRAF V600E plus TERT mutation) underwent total thyroidectomy followed by radioactive iodine (RAI) ablation. Four patients with high risk (67%) experienced local recurrence, with 3 of them also developing distant metastasis. Thus, patients with high-risk alterations were more likely to experience persistence or recurrence and distant metastasis than patients with intermediate risk. In a multivariable analysis incorporating patient age, sex, cancer size, ThyroSeq molecular risk group, extrathyroidal extension, lymph node positivity, American Thyroid Association risk, and RAI ablation, only cancer size (hazard ratio, 1.36; 95% CI, 1.02-1.80) and ThyroSeq CRC molecular risk group (high vs intermediate and low: hazard ratio, 6.22; 95% CI, 1.04-37.36) were associated with structural recurrence. Conclusions and Relevance: Among the 6% of patients with high-risk ThyroSeq CRC alterations in this cohort study, the majority experienced recurrence or distant metastasis despite initial treatment with total thyroidectomy and RAI ablation. In contrast, patients with low- and intermediate-risk alterations had a low recurrence rate. Preoperative knowledge of molecular alteration status at diagnosis may allow for deescalation of initial surgery and refining of the intensity of postoperative surveillance in patients presenting with Bethesda V and VI thyroid nodules.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今夜天将放晴完成签到,获得积分10
刚刚
大方树叶完成签到,获得积分10
1秒前
P1atinum完成签到,获得积分10
1秒前
蓝兰完成签到,获得积分10
1秒前
研友_Zle7a8完成签到,获得积分10
1秒前
尊敬凝荷完成签到,获得积分10
1秒前
Owen的应助被鲸落采纳,获得10
1秒前
甜甜的小虾米完成签到,获得积分10
1秒前
1秒前
宋敏瑜完成签到,获得积分10
1秒前
kingyuan完成签到,获得积分10
2秒前
深情安青的应助被彩色的胜采纳,获得10
2秒前
1L完成签到,获得积分10
2秒前
叭叭完成签到,获得积分10
2秒前
XL完成签到,获得积分10
2秒前
2秒前
而已发布了新的文献求助10
2秒前
kobe完成签到,获得积分10
3秒前
十四完成签到 ,获得积分10
3秒前
常青完成签到,获得积分10
3秒前
roshyun完成签到,获得积分10
3秒前
koko完成签到,获得积分10
4秒前
kelsiwang完成签到,获得积分10
4秒前
端庄的夏寒完成签到,获得积分10
4秒前
qimedchem完成签到,获得积分10
4秒前
yangmiemie完成签到,获得积分10
4秒前
5秒前
Wahaha发布了新的文献求助10
5秒前
5秒前
jiujiu圆圆个完成签到,获得积分10
6秒前
呆萌的海亦完成签到,获得积分10
6秒前
广州队发布了新的文献求助10
6秒前
高贵靖柔完成签到,获得积分10
6秒前
coolru的应助被无限凛采纳,获得10
6秒前
科研通AI6.3的应助被无字诉题采纳,获得10
6秒前
6秒前
xx完成签到 ,获得积分10
7秒前
陈文海发布了新的文献求助10
7秒前
千千完成签到,获得积分10
7秒前
董竹君完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180275
求助须知:如何正确求助?哪些是违规求助? 9570366
关于积分的说明 21810725
捐赠科研通 7776380
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479042